| A Study of BGM0504 in Early T2DM With Obesity (NCT07743983) | BrightGene Bio-Medical Technology Co., Ltd. | 2026-08-30 |
| A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes (NCT07658560) | BrightGene Bio-Medical Technology Co., Ltd. | 2026-06-30 |
| A Study of BGM0504 Tablets in Healthy Chinese Subjects (NCT07566572) | BrightGene Bio-Medical Technology Co., Ltd. | 2026-03-26 |
| Bioequivalence Study of BGM0504 Injection (NCT07382908) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-12-23 |
| A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants (NCT07294235) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-12-05 |
| A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects (NCT07239973) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-10-21 |
| Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women (NCT07224399) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-10-09 |
| Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects (NCT07166081) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-08-11 |
| A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia (NCT07064486) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-07-04 |
| A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function (NCT06929156) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-05-06 |
| A Study of BGM0504 in Participants With Obesity (NCT06911203) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-04-03 |
| A Study of BGM0504 in Overweight or Obese Participants (NCT06920056) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-03-24 |
| A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise (NCT06716203) | BrightGene Bio-Medical Technology Co., Ltd. | 2024-12-02 |
| A Study of BGM0504 in Participants with Type 2 Diabetes (NCT06716216) | BrightGene Bio-Medical Technology Co., Ltd. | 2024-11-29 |
| Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Injection in Non-diabetic Overweight or Obese Adult Subjects (NCT06714955) | BrightGene Bio-Medical Technology Co., Ltd. | 2024-10-21 |
| A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects (NCT06973681) | BrightGene Bio-Medical Technology Co., Ltd. | 2023-10-13 |
| A Study of BGM0504 in Chinese Patients With Type 2 Diabetes (NCT06974825) | BrightGene Bio-Medical Technology Co., Ltd. | 2023-08-30 |